• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Hongxue, ZHANG Lei. Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014[J]. Journal of China Pharmaceutical University, 2016, 47(2): 247-250. DOI: 10.11665/j.issn.1000-5048.20160220
Citation: LI Hongxue, ZHANG Lei. Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014[J]. Journal of China Pharmaceutical University, 2016, 47(2): 247-250. DOI: 10.11665/j.issn.1000-5048.20160220

Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014

More Information
  • According to “2015 State of Innovation” released by Thomson Reuters, China Pharmaceutical University ranked the first in the field of heterocyclic compounds in 2010-2014 among innovation agencies in Asia. In order to fully understand the situation of the new drug research of this university, this paper analyzes its patent application from 2010 to 2014 in the field of heterocyclic compounds. The key applications were summarized. In summary, this university showed its advantage of high filings and high licensing rate in the field of heterocyclic compounds, yet with the shortcomings of low patent applications in PCT. Furthermore, suggestions have been made for the intellectual property management of this university.
  • [1]
    Bai XG,Xu LX,et al.Advance in research of cyclin-dependent kinase 2 inhibitors based on the structures of target proteins [J].Chin New Drugs J(中国新药杂志),2011, 20(17):1667-1672.
    [2]
    Zhang YH, Peng SX. Advances in the research of nitric oxide-donating drugs[J].J China Pharm Univ(中国药科大学学报),2006,37(5):387-396.
    [3]
    Jiang SM,Wang ZX.Research progress of Polo-like kinase 1 and prognosis and treatment in human carcinomas[J].Mod Oncol现代肿瘤医学),2013,21(3):650-653.
    [4]
    Feng F,Liu WY,Guo QL,et al.Anti-tumor QSAR of gambogic acid analogues[J].J China Pharm Univ(中国药科大学学报),2007,38(4):311-314.
    [5]
    Zhou ZT,Wang JW.PhaseⅠhuman tolerability trial of gambogic acid[J].Chin New Drugs J(中国新药杂志),2007,16(1):79-82.
    [6]
    Lu T,Lu S,Li HF,et al.Advances and prospects on signal transduction pathways in tumor and R&D of the related drugs(I)[J].J China Pharm Univ(中国药科大学学报),2008,39(3):193-199.
  • Related Articles

    [1]HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101
    [2]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [3]LIU Yanhong, CHEN Liqing, ZHANG Xintong, GAO Zhonghao, HUANG Wei. Research progress of tumor immunomodulation strategies based on nanodrug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023021501
    [4]WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405
    [5]ZHOU Xinyuan, LIU Nan, ZHANG Pan, HUO Meirong. Advances in research on therapeutic strategies of targeting pancreatic cancer stroma[J]. Journal of China Pharmaceutical University, 2021, 52(6): 653-662. DOI: 10.11665/j.issn.1000-5048.20210602
    [6]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [7]YANG Shan, XU Cheng, YAO Jing. Strategies of nano drug delivery system applied in anti-angiogenic therapy[J]. Journal of China Pharmaceutical University, 2019, 50(1): 11-18. DOI: 10.11665/j.issn.1000-5048.20190102
    [8]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [9]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [10]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.
  • Cited by

    Periodical cited type(2)

    1. 翟允耀,章晓骅. 化学仿制药制剂开发中晶型研究思路探讨. 药品评价. 2024(02): 131-133 .
    2. 梁霖霖,王志伟,何小双,衡伟利,钱帅,高缘,张建军,魏元锋. 机械外力对中药提取物晶体学固态形式及溶出速率的影响研究——以女贞子提取物为例. 中国药科大学学报. 2024(06): 767-774 . 本站查看

    Other cited types(0)

Catalog

    Article views (1076) PDF downloads (2155) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return